The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma

Stopped The DSMB recommended to stop the study after the interim analysis, as the results shown a superiority of the embolization arm. 247 patient were finally enrolled.

Conditions

• Hematoma, Subdural, Chronic
• Brain Diseases
• Central Nervous System Diseases
• Wounds and Injuries

Interventions

• DEVICE: Middle Meningeal Artery Embolization
• PROCEDURE: Standard Management

Sponsor

University Hospital, Montpellier